You're reading the free version. Trader adds the live tape and alerts.
Start tracking
DNTH Sale Disclosure
Randhawa Simrat · SEC Form 4 · Filed Sep 3, 2026
Sale
Calculated transaction value
$766.59K
Randhawa Simrat EVP, Head Of R&d
DNTH
Transaction date
Sep 1, 2026
Public filing date
Sep 3, 2026
Filing lag
Filed 2 days later
DNTH daily price context
Close on/before transaction
$106.62
Sep 1, 2026
First close after public filing
$108.1
Sep 4, 2026
30-day return after filing
-18.56%
Through Oct 5, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 7,215 shares @ $106.25
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001992260-26-000009
Filing cohort
Transactions in this filing
Showing 9 of 9
Trades
9
Issuers
1
Estimated value
$2.94M
Buys / sales
0 / 3
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Dianthus Therapeutics, Inc. /de/ DNTH | Exercise | Sep 1, 2026 | $134.1K |
| Dianthus Therapeutics, Inc. /de/ DNTH | Exercise | Sep 1, 2026 | $136.04K |
| Dianthus Therapeutics, Inc. /de/ DNTH | Exercise | Sep 1, 2026 | $206.91K |
| Dianthus Therapeutics, Inc. /de/ DNTH | Sale | Sep 1, 2026 | $1.42M |
| Dianthus Therapeutics, Inc. /de/ DNTH | Exercise | Sep 1, 2026 | $0 |
| Dianthus Therapeutics, Inc. /de/ DNTH | Exercise | Sep 1, 2026 | $0 |
| Dianthus Therapeutics, Inc. /de/ DNTH | Sale | Sep 1, 2026 | $273.49K |
| Dianthus Therapeutics, Inc. /de/ DNTH Current | Sale | Sep 1, 2026 | $766.59K |
| Dianthus Therapeutics, Inc. /de/ DNTH | Exercise | Sep 1, 2026 | $0 |